MXCT vs BVS โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BVS Captures Institutional Edge (2โ2 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Bioventus Inc. Class A Common Stock (BVS) driven by superior Valuation, Growth & Margin while MXCT counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, MXCT trades at N/M Forward P/E with -85.5% operating margin (+48.7% YoY revenue) versus BVS at 11.1x Forward P/E and 10.1% operating margin (+2.7% YoY). In options structure, MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BVS sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MXCT Revenue | BVS Revenue | MXCT Op. Margin | BVS Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $10M | $340M | -93.7% | 9.2% | BVS |
| FY2020 | $20M | $320M | -71.6% | 6.6% | BVS |
| FY2021 | $20M | $430M | -84.3% | 2.8% | BVS |
| FY2022 | $30M | $510M | -95.2% | -32.7% | BVS |
| FY2023 | $20M | $510M | -247.7% | -16.0% | BVS |
| FY2024 | $20M | $570M | -230.5% | -2.7% | BVS |
| FY2025 | $20M | $570M | -247.6% | 9.5% | BVS |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MXCT | BVS | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $132.2M | $681.3M | Larger Scale | BVS |
| Trailing P/E Ratio Valuation | N/M | 12.3x | Lower Multiple | BVS |
| Forward P/E Ratio Valuation | N/M | 11.1x | Lower Multiple | BVS |
| Revenue Growth (YoY) Growth | +48.7% | +2.7% | Higher Growth | MXCT |
| Operating Margin (TTM) Profitability | -85.5% | 10.1% | Higher Margin | BVS |
| Net Profit Margin Profitability | -81.4% | 9.8% | Higher Margin | BVS |
| Return on Equity (ROE) Capital Efficiency | -16.9% | 25.8% | Higher ROE | BVS |
| 52-Week Range Position Momentum | 63% ($1โ$2) | 36% ($6โ$16) | Stronger Trend | MXCT |
| Beta / 30D Volatility Risk Regime | 1.19ฮฒ ยท 96% Vol | 0.85ฮฒ ยท 74% Vol | Lower Realized Risk | BVS |
| Unified Institutional Score Composite Signal | 41.7 / 100 (SELL) | 46.2 / 100 (HOLD) | Higher Composite | BVS |